Abiopharma

FDA approve SIPONIMOD

FDA approve DOCETAXEL

FDA approve AXITINIB

FDA approve COLESEVELAM HYDROCHLORIDE

FDA approve CABERGOLINE

FDA approve ZIDOVUDINE

FDA approve HYDRALAZINE HYDROCHLORIDE

FDA approve MARALIXIBAT

FDA approve ARIPIPRAZOLE

FDA approve GOLIMUMAB